Vioxx Research Today is a free monthly online journal that collates and summarizes the latest research about Vioxx, including details on osteoarthritis, side-effects, trials, stroke, heart attack.

Volume 4 (2007), Issue 1 (January)

1. Exercise can be pyrogenic in humans.
   Am J Physiol Regul Integr Comp Physiol, 292(1): R143-9. [Abstract] [Full-text]
2. Co-Administration of Acetyl-11-Keto-beta-Boswellic Acid, a Specific 5-Lipoxygenase Inhibitor, Potentiates the Protective Effect of COX-2 Inhibitors in Kainic Acid-Induced Neurotoxicity in Mice.
   Pharmacology, 79(1): 34-41. [Abstract] [Full-text]
3. Herbal medicine for low back pain: a Cochrane review.
   Spine, 32(1): 82-92. [Abstract] [Full-text]
4. The efficacy of rofecoxib 50 mg and hydrocodone/acetaminophen 7.5/750 mg in patients with post-arthroscopic pain.
   Curr Med Res Opin, 23(1): 195-206. [Abstract] [Full-text]
5. Coxibs and heart disease: what we have learned and what else we need to know.
   J Am Coll Cardiol, 49(1): 1-14. [Abstract] [Full-text]
6. A pathogenetic mechanism for COX-2 inhibitor-induced cardiovascular events proposed to be useful in structuring medical testimony in rofecoxib trials.
   Med Hypotheses. [Abstract] [Full-text]
7. Interaction between inhibitors of inducible nitric oxide synthase and cyclooxygenase in adjuvant-induced arthritis in female albino rats: an isobolographic study.
   Eur J Pharmacol, 556(1): 190-9. [Abstract] [Full-text]
8. The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction.
   Heart, 93(2): 189-94. [Abstract] [Full-text]
9. Preconditioning stress prevents cold restraint stress-induced gastric lesions in rats: roles of COX-1, COX-2, and PLA2.
   Dig Dis Sci, 52(2): 478-87. [Abstract] [Full-text]

© 2004-2008 Vioxx Research Today. All Rights Reserved.